Correlation between Serum Estradiol in the Follicular Phase of the Ovarian Cycle and Decay Accelerating Factor (DAF) Expression on Red Blood Cells and Coxsackievirus B3-Induced Hemagglutination in Young Cycling Women
- 27 January 2004
- journal article
- research article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 51 (2) , 180-187
- https://doi.org/10.1046/j.8755-8920.2003.00142.x
Abstract
Decay accelerating factor (DAF) is a widely distributed glycoprotein which aids in the inactivation of complement. DAF is also a cellular receptor for certain group B coxsackieviruses (CVB) and is responsible for the viral hemagglutinating activity for human red blood cells (RBC). Healthy, young female volunteers donated blood on days 11 and 22 of the ovarian cycle. Samples were categorized into luteal and follicular phases based on serum progesterone level (P4 either < 2.0 ng/mL, follicular; P4 > or = 2.0 ng/mL, luteal) and analyzed by flow cytomtery for DAF expression on RBC and CD21 + B lymphocytes. Cycling females showed significant variation in CVB-induced hemagglutination and % RBC or CD19 + cells which were DAF +. There was a strong correlation between serum estradiol levels and % RBC expressing DAF (P < 0.01) in the follicular, but not in the luteal ovarian phase. Infection of white blood cells with green-fluorescent protein CVB (GFP-CVB) showed a correlation between infectivity of CD19+ cells and DAF expression. This indicates that women may show differential susceptibility to CVB infection in the luteal and follicular phases of the ovarian cycle.Keywords
This publication has 20 references indexed in Scilit:
- Human decay-accelerating factor expressed on rat hearts inhibits leukocyte adhesionTransplant International, 2003
- Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti‐IFCTransfusion, 2002
- Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protectionJournal of Clinical Investigation, 2002
- Cell Cycle Status Affects Coxsackievirus Replication, Persistence, and Reactivation In VitroJournal of Virology, 2002
- Comparative analysis of two coxsackievirus B3 strains: Putative influence of virus-receptor interactions on pathogenesisJournal of Medical Virology, 2002
- Divergent Effects of Ovarian Steroids on Neuronal Survival during Experimental Allergic Encephalitis in Lewis RatsExperimental Neurology, 2001
- The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.The Journal of Experimental Medicine, 1987
- Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.Proceedings of the National Academy of Sciences, 1987
- Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids.The Journal of Experimental Medicine, 1987
- Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1985